TXA9, a cardiac glycoside from Streptocaulon juventas, exerts a potent anti-tumor activity against human non-small cell lung cancer cells in vitro and in vivo

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Growth inhibitory effect of cardiac glycosides and aglycones on neoplastic cells: in vitro and in vivo studies.

Osamu Shiratori · PubMed · 1967 · 69 citations

Medicine, Oncology, Pharmacology +12

α‐Fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase‐3‐like proteases

Elena Dudich, Lidia Semenkova, I.V. Dudich et al. · European Journal of Biochemistry · 1999 · 56 citations

Life Sciences, Cancer Biology, Oncology +16

Cytotoxic Cardenolides from <i>Streptocaulon griffithii</i>

Xiaohui Zhang, Huilin Zhu, Qiang Yu et al. · Chemistry & Biodiversity · 2007 · 22 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Cardenolide glycosides from root of Streptocaulon juventas

Rui Xue, Na Han, Chun Ye et al. · Phytochemistry · 2012 · 22 citations

Life Sciences, Botany, Plant Sciences +6